市場調査レポート
商品コード
1497763
分析標準試料市場:タイプ、手法、用途別-2024-2030年の世界予測Analytical Standards Market by Type (Inorganic, Organic), Technique (Chromatography, Physical Properties Testing, Spectroscopy), Application - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
分析標準試料市場:タイプ、手法、用途別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
|
分析標準試料市場規模は、2023年に26億3,000万米ドルと推定され、2024年には28億2,000万米ドルに達し、CAGR 7.32%で2030年には43億2,000万米ドルに達すると予測されています。
分析標準試料は、ラボや研究機関を含む様々な産業において、分析測定の正確性、精度、信頼性を確保するために使用される標準物質を指します。これらの標準物質は、クロマトグラフィー、分光法、滴定、元素分析などの分析技術で採用されるバリデーション、キャリブレーション、品質管理プロセスにおいて重要な役割を果たしています。食品安全基準に対する意識の高まりは、認証標準物質を使用した高品質の検査に対する要求の急増につながっています。さらに、プロテオミクスやメタボロミクスのアプリケーションにおける分析材料の需要の高まりも、分析標準試料の成長につながりました。分析標準試料は、プロテオミクスとメタボロミクスにおける共通の参照点を提供することにより、試験室間のデータ比較を容易にし、両アプリケーションにおいてより良い結果をもたらします。しかし、分析標準試料の製造と合成に伴う複雑さ、保管や輸送の難しさは、分析標準試料メーカーやプロバイダーにとって大きな課題となっています。企業は研究開発の実践と品質管理プロセスの活用に継続的に取り組み、事業の成長を促進しています。さらに、臨床試験の増加や高度な分析技術の革新が、分析標準試料分野の今後の成長を促進しています。企業は、高度な計算手法とデータ解析を用いて設計された合成標準物質や生体模倣代替物質を導入しています。これらの材料は、性能パラメータを損なうことなく、天然のものと比較して安定性、再現性、費用対効果を向上させます。
主な市場の統計 | |
---|---|
基準年[2023] | 26億3,000万米ドル |
推定年[2024] | 28億2,000万米ドル |
予測年 [2030] | 43億2,000万米ドル |
CAGR(%) | 7.32% |
地域別インサイト
米国やカナダを含む南北アメリカでは、顧客は高品質な製品とサービスを優先する一方で価格にも敏感であり、リピート購入の多さにつながっています。食品・水治療やクリーンエネルギーへの取り組みなど、この地域の最近の投資も分析標準試料の著しい成長を目の当たりにしています。同様に、欧州では、消費者保護とビジネス慣行を規定する共通の規制を各国が共有しています。消費者は持続可能性と製品品質の両方を重視しながら購入を決定しています。再生可能エネルギー、デジタルトランスフォーメーション、電気自動車(EV)のインフラ整備への投資が増加し、分析標準試料分野の拡大に影響を与えています。欧州特許庁は、環境の持続可能性に関連するバイオテクノロジー特許の大幅な伸びを報告しています。さらに、中東・アフリカ地域は、人口の増加と産業部門の発展により、事業拡大の機会をもたらしています。消費者の嗜好はこの地域内でも様々で、一般的には手頃な価格の良質な製品に傾いています。通信インフラ整備、再生可能エネルギー・プロジェクト、海水淡水化技術への投資が増加しており、同地域でのビジネスが拡大しています。さらに、中国、日本、インドなどの新興国は、製薬産業が急成長しているため、メーカーにとって大きな成長機会となっています。これらの国々における分析標準試料の需要増加は、ヘルスケア支出の増加、中流階級の人口増加、ジェネリック医薬品市場の拡大に起因しています。中国やインドなどの国々には多様な消費者層が存在し、この国の経済成長への参入を目論む企業にとって計り知れない可能性があります。両国政府は、自立を促進し、輸入依存を減らすための計画を通じて、国内生産を後押しすることを目的としたさまざまなプログラムを開始しています。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは、分析標準試料市場におけるベンダーの市場ポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、分析標準試料市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、分析標準試料市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
TABLE 335
[198 Pages Report] The Analytical Standards Market size was estimated at USD 2.63 billion in 2023 and expected to reach USD 2.82 billion in 2024, at a CAGR 7.32% to reach USD 4.32 billion by 2030.
Analytical standards refer to the reference materials used in various industries, including laboratories and research institutions, to ensure the accuracy, precision, and reliability of their analytical measurements. These standards play a crucial role in the validation, calibration, and quality control processes employed by analytical techniques such as chromatography, spectroscopy, titration, and elemental analysis. Increased awareness about food safety norms has led to an upsurge in the requirement for high-quality testing using certified reference materials. In addition, the rising demand for analytical materials in proteomics and metabolomics applications has also led to the growth of analytical standards. Analytical standards facilitate interlaboratory data comparisons by providing a common point of reference in proteomics and metabolomics, resulting in better outcomes in both applications. However, the complexity associated with the production and synthesis of analytical standards, along with their difficulties in storage and transportation, has led to a significant challenge for analytical standards manufacturers and providers. Companies continuously work toward research and development practices and leveraging quality control processes to promote business growth. Moreover, the rising number of clinical trials and innovations of advanced analytical technologies have fostered the future growth of the analytical standards sector. Companies are introducing synthetic reference materials and biomimetic alternatives designed using advanced computational methods and data analytics. These materials offer increased stability, reproducibility, and cost-effectiveness compared to natural counterparts without compromising performance parameters.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.63 billion |
Estimated Year [2024] | USD 2.82 billion |
Forecast Year [2030] | USD 4.32 billion |
CAGR (%) | 7.32% |
Regional Insights
In the Americas, countries including the United States and Canada, customers prioritize quality products and services while being price-conscious, contributing to a high volume of repeat purchases. Recent regional investments, including food and water treatments and clean energy initiatives, have also witnessed significant growth in the analytical standards. Similarly, in Europe, the countries share common regulations that govern consumer protection and business practices within their markets. Consumers value both sustainability and product quality while making purchase decisions. Increased investments have been made in renewable energy sources, digital transformation initiatives, and electric vehicle (EV) infrastructure development, impacting the expansion of analytical standards sectors. The European Patent Office has reported substantial growth in biotechnology patents related to environmental sustainability. Furthermore, the Middle East & Africa region presents opportunities for expanding businesses owing to its growing population and developing industrial sector. Consumer preferences vary distinctly within this region, generally leaning toward affordable products with good quality. The increasing investments in telecommunications infrastructure improvement, renewable energy projects, and water desalination technologies are expanding businesses in the region. Moreover, emerging countries such as China, Japan, and India represent a significant growth opportunity for manufacturers due to their burgeoning pharmaceutical industries. The increasing demand for analytical standards within these countries can be attributed to rising healthcare spending, growing middle-class populations, and expanding generic drug markets. Countries such as China and India have a diverse consumer base that offers immense potential for businesses planning to tap into the country's growing economy. The governments of both countries have initiated various programs aimed at boosting domestic production through schemes to promote self-reliance and reduce import dependence.
Market Insights
The market dynamics represent an ever-changing landscape of the Analytical Standards Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Analytical Standards Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Analytical Standards Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions
Cayman Chemical introduced Cayman LipiDOT Strips as a research tool to aid scientists in identifying and gaining deeper insights into protein-lipid interactions. By uncovering new lipid-protein interactions, researchers can enhance their understanding of the roles lipids play in modulating protein function, ultimately leading to significant advancements in therapeutic approaches for various diseases. [Published On: 2023-09-26]
Fentanyl Analog Screening Kit Now Available Internationally Through Partnership Between Cayman, CDC, and INCB
Cayman Chemical, partnered with the Centers for Disease Control and Prevention (CDC) and the International Narcotics Control Board (INCB), has granted permission to distribute Fentanyl Analog Screening (FAS) Kits to approved forensic institutions worldwide. The FAS Kit comprises analog reference materials that allow laboratories to screen for 250 different synthetic opioids, including over 210 fentanyl analogs. Since 2018, the CDC has contracted Cayman Chemical, an ISO-accredited producer of reference materials, to manufacture and distribute FAS Kits. These kits are available free of charge through Cayman Chemical; however, laboratories are responsible for covering delivery costs, which include freight charges, customs duties, and administrative fees. [Published On: 2023-05-31]
Cayman Chemical Launch New Traceable Opioid Material Kit
Cayman Chemical, in partnership with the Centers for Disease Control and Prevention (CDC), launched a new product known as the Fentanyl Analog Screening (FAS) Kit - Emergent Drug Panel. This kit is an addition to their existing Traceable Opioid Material Kits (TOM Kits). The FAS Kit - Emergent Drug Panel comprises 60 reference standards that are used for the detection and identification of various substances such as stimulants, hallucinogens, benzodiazepines, synthetic cannabinoids, and the veterinary sedative and analgesic drug xylazine. [Published On: 2023-04-26]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Analytical Standards Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Analytical Standards Market, highlighting leading vendors and their innovative profiles. These include ABCR GmbH, Accustandard Inc., Agilent Technologies, Inc., AnalytiChem GmbH, ASI Standards, Bruker Corporation, Cambrex Corporation, Campro Scientific GmbH, Cayman Chemical Company, Central Drug House (P) Ltd., Crescent Chemical Co., Inc., CRM LABSTANDARD, Extrasynthese, FUJIFILM Wako Pure Chemical Corporation, GFS Chemicals Inc., Honeywell International Inc., Horiba, Ltd., HPC Standards GmbH, HWI pharma services GmbH, Inorganic Ventures, Inc., Labsert Ltd., LGC Standards Ltd., Mallinckrodt Pharmaceuticals PLC, Merck KGaA, PerkinElmer, Inc., Phenomenex Inc. by Danaher Corporation, Qiagen N.V., Restek Corporation, Ricca Chemical Company, LLC, Shimadzu Corporation, SimSon Pharma Limited, SMS Pharmaceuticals Ltd., SPEX CertiPrep Inc., Sussex Research Laboratories Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.
Market Segmentation & Coverage